About 9,650,000 results
Open links in new tab
AbbVie News Center - News
AbbVie Submits Biologics License Application to the FDA for ...
AbbVie Announces Positive Topline Results from Phase 3 TEMPO …
AbbVie Parkinson’s drug from $8.7B Cerevel buyout scores
AbbVie’s $8.7bn Parkinson’s disease drug shines in Phase III trial
AbbVie Completes Acquisition of Cerevel Therapeutics
AbbVie to Acquire ImmunoGen, including its Flagship Cancer ... - News
AbbVie's Parkinson's Disease drug meets main goal in late-stage …
AbbVie Seeks Accelerated FDA OK of Teliso-V in Non-Small Cell …
AbbVie to Acquire Cerevel Therapeutics in Transformative …